Cargando…
New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis
BACKGROUND AND STUDY AIMS : Endoscopic retrograde cholangiopancreatography (ERCP) is often performed in patients with primary sclerosing cholangitis (PSC). Our aim was to validate a treatment approach with the objective of decreasing ERCP related adverse events (AEs). PATIENTS AND METHODS : All pati...
Autores principales: | Navaneethan, Udayakumar, Lourdusamy, Dennisdhilak, Gutierrez, Norma G, Zhu, Xiang, Vargo, John J, Parsi, Mansour A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546902/ https://www.ncbi.nlm.nih.gov/pubmed/28791317 http://dx.doi.org/10.1055/s-0043-102398 |
Ejemplares similares
-
Gut Inflammation in Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis-Contrasting Pattern of Liver-gut Cross Talk
por: Navaneethan, Udayakumar
Publicado: (2015) -
Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn’s disease
por: Navaneethan, Udayakumar, et al.
Publicado: (2016) -
ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
por: Natt, Navneet, et al.
Publicado: (2022) -
Colorectal cancer resection rates in patients with inflammatory bowel disease: a population-based study
por: Navaneethan, Udayakumar, et al.
Publicado: (2018) -
Safety of ERCP in patients with liver cirrhosis: a national database study
por: Navaneethan, Udayakumar, et al.
Publicado: (2017)